Loading clinical trials...
Loading clinical trials...
Pilot Study of an Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer
The study will include 50 patients newly diagnosed with low-risk thyroid cancer ranging from 18-80 years of age. After scheduling their surgeon visit, the investigators will enroll patients and measure their intended treatment choice, baseline awareness of the three treatment options, expected outcomes, self-efficacy, and activation. The participants will then be randomized 1:1 and deliver the CQUPLE intervention to the intervention group. The control group will receive usual care, which involves providing no disease or treatment specific information outside the surgeon visit. The study team will repeat all measures prior to the surgical consult and after the surgical consult. The study team will record the patients' actual treatment choice after the consult.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
The University of Michigan Cancer Center
Ann Arbor, Michigan, United States
Start Date
September 18, 2023
Primary Completion Date
December 20, 2025
Completion Date
December 20, 2025
Last Updated
February 17, 2026
50
ACTUAL participants
Usual Care
OTHER
CQUPLE
OTHER
Lead Sponsor
University of Michigan Rogel Cancer Center
Collaborators
NCT06316895
NCT07092514
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06524167